Moderna Plunges After Melanoma Data Leak — SkimNews
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Moderna stock plunged after cancer-vaccine data were shared on social media.
- Moderna’s record August rally was threatened by leaked melanoma data, while Merck shares fell on the eagerly anticipated cancer-vaccine results.
Why it matters: The reaction was not confined to one company: Moderna’s record August rally was threatened by the reported melanoma data, and Merck shares fell too. For these two companies, the immediate consequence was a market decline tied to the anticipated cancer-vaccine results.
Ask SkimNews
